Loading this company
Chemed Corporation
CHEPrices in USD
TickerWorth ScoreC51/100
What we think
Priced within our range of $229.21 to $570.27.
Price
$512.38USD down −$3.06 (−0.59%)
Quoted · Prices are delayed.
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 3 models, on today’s numbers
$229.21–$570.27
What the price needs: revenue growth of 7.5%/yr for 5 years (our model assumes 6.4%).
Led by discounted cash flow (DCF) · Steady cash-flow business
Price $512.38Priced · Prices are delayed.
Is it a good business?
- Valuation33 out of 100
- Growth83 out of 100
- Financial health33 out of 100
- Dividend75 out of 100
- Past performance100 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
$571.60 across 5 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. It operates in the Medical Care Facilities industry (Healthcare sector), headquartered in United States. The company employs roughly 15,811 people.
Key stats
52-week range$365.21–$557.00
- Open
- $518.79
- Day high
- $519.79
- Day low
- $509.73
- Previous close
- $515.44
- Volume
- 89,398 · 0.57× avg
- Average volume
- 157,240
- Market cap
- $6,696,786,432.00
- P/E (TTM)
- 25.15
- Earnings per share
- $20.37
- Beta
- 0.51
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
- Reported quarterly or annual results
- Reported shareholder vote results
- Reported quarterly or annual results
- Signed a material agreement
- Reported quarterly or annual results
- Reported quarterly or annual results
- Changed leadership or its board
Top news
No recent headlines we can cite for this company.
Insider trades
The 90-day buying-and-selling read is part of Pro. See plans
- LEE SPENCER SOption exercise · $5,388,289.65
- LEE SPENCER SShares withheld (tax) ·
Not investment advice. TickerWorth Score is a model output.